The groundbreaking approach of the medication represents a significant advance in the care of type 2 diabetes. Different to existing medications, tirzepatide affects two pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide591403.widblog.com/96924857/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment